
Nutrien Ltd. Revenue | NTR
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue Nutrien Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 20.9 B | 20 B | 19.6 B | 4.55 B | 4.46 B | 6.28 B | 7.12 B | 7.3 B | 7.93 B | 8.72 B |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.9 B | 4.46 B | 10.7 B |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Agricultural inputs industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Marrone Bio Innovations
MBII
|
44.3 M | - | -5.9 % | $ 180 M | ||
|
Yield10 Bioscience
YTEN
|
60 K | - | 15.32 % | $ 46.6 M | ||
|
Акрон
AKRN
|
179 B | - | - | - | ||
|
ФосАгро
PHOR
|
440 B | - | - | - | ||
|
The Mosaic Company
MOS
|
12.1 B | $ 19.76 | -4.75 % | $ 6.27 B | ||
|
CF Industries Holdings
CF
|
7.08 B | $ 113.77 | -4.67 % | $ 18.4 B | ||
|
Corteva
CTVA
|
17.4 B | $ 8.37 | -5.16 % | $ 5.69 B | ||
|
Bioceres Crop Solutions Corp.
BIOX
|
335 M | $ 0.2 | 5.73 % | $ 12.6 M | ||
|
American Vanguard Corporation
AVD
|
515 M | $ 0.73 | 0.15 % | $ 20.8 M | ||
|
Arcadia Biosciences
RKDA
|
4.86 M | $ 0.19 | 0.53 % | $ 260 K | ||
|
ICL Group Ltd
ICL
|
7.15 B | $ 4.18 | -3.35 % | $ 5.39 B | ||
|
Intrepid Potash
IPI
|
298 M | $ 29.96 | -3.23 % | $ 390 M | ||
|
FMC Corporation
FMC
|
1.08 B | $ 4.68 | -6.21 % | $ 586 M | ||
|
Origin Agritech Limited
SEED
|
91.3 M | $ 0.66 | -0.88 % | $ 4.94 M | ||
|
The Scotts Miracle-Gro Company
SMG
|
3.41 B | $ 64.09 | 2.46 % | $ 3.69 B | ||
|
CVR Partners, LP
UAN
|
606 M | $ 95.44 | -7.04 % | $ 1.01 B | ||
|
China Green Agriculture
CGA
|
75.3 M | - | 0.51 % | $ 27.6 M |